The global Anal Fissure Treatment Market is estimated to be valued at US$ 1,039.3 Mn in 2023 and is expected to exhibit a CAGR of 5.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Anal fissure is a tear in the lining of the anal canal. It causes symptoms like pain or bleeding during and after bowel movements. The main aim of treatment is to relieve pain and promote healing of the anal fissure. Non-surgical treatments like calcium channel blockers, nitrates and Botox injections are becoming increasingly popular due to quick relief and fewer side effects.
Market key trends:
One of the major trends driving the market growth is the increasing preference for non-surgical treatments over surgical methods. Non-surgical treatments like calcium channel blockers such as diltiazem and nifedipine have shown promising results in pain relief and fissure healing. Also, Botox injections help relax internal sphincter muscle and increase blood supply to promote healing. In addition, advances in drug delivery systems such as submucosal injection technique have minimized procedure related pain and improved clinical efficacy of Botox treatment. Such innovations are boosting the adoption of non-surgical treatments among patients and physicians.
Segment Analysis
The global anal fissure treatment market is dominated by the topical drugs sub segment due to ease of use and availability in both prescription as well as over-the-counter drugs. Topical drugs avoid the use of invasive procedures, thus enabling faster recovery and relief from anal fissure symptoms.
Key Takeaways
The Global Anal Fissure Treatment Market Size is expected to witness high growth, exhibiting CAGR of 5.3% over the forecast period, due to increasing incidence of anal fissure cases owing to rising bowel issues.
Regional analysis
North America is expected to dominate the global anal fissure treatment market over the forecast period due to growing awareness regarding anal fissure treatments and favorable reimbursement policies in the region.
Key players
Key players operating in the anal fissure treatment market are Allergan, Novartis, Pfizer, Takeda Pharmaceutical Company, Cook Medical, Medtronic, Johnson & Johnson, AstraZeneca, GlaxoSmithKline, Sanofi, Merck, Abbott Laboratories, Bayer, Astellas Pharma, Aurobindo Pharma, Ferring Pharmaceuticals, Salix Pharmaceuticals, Eli Lilly, Bristol-Myers Squibb, Boehringer Ingelheim.
Get More Insights Here
https://healthcarelatesteditionnews.blogspot.com/2023/12/non-surgical-treatments-is-fastest.html
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian